TITLE

Pharmacokinetic detection of penicillin excreted in urine using a totally internally reflected resonance light scattering technique with cetyltrimethylammonium bromide

AUTHOR(S)
Cheng Zhi Huang; Ping Feng; Yuan Fang Li; Ke Jun Tan
PUB. DATE
May 2005
SOURCE
Analytical & Bioanalytical Chemistry;May2005, Vol. 382 Issue 1, p85
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
A quantitative analysis method for penicillins including ampicillin (AmP), benzyl penicillin (BP), oxacillin (OA) and amoxycillin (AmO) is proposed that makes use of the totally internally reflected resonance light scattering (TIR-RLS) signal from the penicillin at the H2O/CCl4 interface in the presence of cetyltrimethylammonium bromide (CTMAB), and enables the pharmacokinetics of penicillin taken orally and excreted through urine to be monitored. Penicillin is coadsorbed with CTMAB at the H2O/CCl4 interface in neutral solution, resulting in the formation of ion associates that display greatly enhanced TIR-RLS signals (maximum at 368-372 nm). This enhanced TIR-RLS intensity was found to be proportional to the penicillin concentration over the range 0.2×10-6 to 2.2×10-6 mol L-1, with limits of determination (3s) of 5.0×10-8 to 7.0×10-8 mol L-1. Pharmacokinetics studies performed using the present method show that the excretion of orally-taken ampicillin through urine has a half-time of 1.05 h and an excremental quantum over 8 h of 49.3%, respectively.
ACCESSION #
17052017

 

Related Articles

  • THE PHARMACOKINETICS OF NORPACE. Karim, Aziz // Angiology;Jan1975 Part 2, Vol. 26, p85 

    Focuses on the usability of drug metabolism and pharmacokinetic studies on a new drug production. Stage of drug development; Excretion of radioactive disopyramide; Determination of the plasma and urine levels of disopyramide obtained after administration of the drug in aqueous solution.

  • Pharmacokinetics of Perfluorooctanoate in Cynomolgus Monkeys. Butenhoff, J. L.; Kennedy Jr., G. L.; Hinderliter, P. M.; Lieder, P. H.; Jung, R.; Hansen, K. J.; Gorman, G. S.; Noker, P. E.; Thomford, P. J. // Toxicological Sciences;Dec2004, Vol. 82 Issue 2, p394 

    The pharmacokinetics of perfluorooctanoate (PFOA) in cynomolgus monkeys were studied in a six-month oral capsule dosing study of ammonium perfluorooctanoate (APFO) and in a single-dose iv study. In the oral study, samples of serum, urine, and feces were collected every two weeks from monkeys...

  • Disposition kinetics and urinary excretion of cefpirome after intravenous injection in buffalo calves. Rajput, Neetu; Dumka, Vinod K.; Sandhu, Harpal S. // Journal of Veterinary Science;2008, Vol. 9 Issue 1, p21 

    We investigated the disposition kinetics and urinary excretion of cefpirome in buffalo calves after a single intravenous administration of 10 mg/kg. Also, an appropriate dosage regimen was calculated. At 1 min after injection, the concentration of cefpirome in the plasma was 57.4 ± 0.72...

  • Pharmacokinetics of 2-chloro-2′-deoxyadenosine administered subcutaneously or by continuous intravenous infusion. Sonderegger, Theodor; Betticher, Daniel C.; Cerny, Thomas; Lauterburg, Bernhard H. // Cancer Chemotherapy & Pharmacology;Jul2000, Vol. 46 Issue 1, p40 

    Purpose: Cladribine (2-chlorodeoxyadenosine, 2-CDA) is effective in the treatment of various lymphoproliferative disorders. In the standard protocol the compound is administered by continuous intravenous (i.v.) infusion. In order to allow outpatient therapy alternative modes of administration...

  • A simple introduction to pharmacokinetics: Part 2. Hughes, Gwen // Nurse Prescribing;Nov2014, Vol. 12 Issue 11, p552 

    Pharmacokinetics describes the movement and fate of drugs through the body as determined by the processes of absorption, distribution, metabolism and elimination (ADME). The second part of this two-part series aims to provide a basic, ‘no-frills’ overview of the main factors and...

  • Editorial: Perspectives of Pharmacokinetics and Metabolism in Drug Design. Hsieh, Yunsheng // Current Pharmaceutical Design;7/1/2009, Vol. 15 Issue 19, p2169 

    The article discusses various reports published within the issue, including one by W. Tang and A. Y. H. Lu on drug metabolism and pharmacokinetics (DMPK) strategies, one by J. Wang on in vitro approaches for assessing risk associated with new chemicals and another one by J. Fang on the...

  • Subject Index To Volume 2. Bentham, S. // Current Drug Metabolism;Feb2002, Vol. 3 Issue 1, p117 

    Presents subject index to Volume 2 of the journal 'Current Drug Metabolism.' Anthracyclines; Bestastatin; Brain cytochrome P450; Brain microdialysis technique to study drug transport; Chimeragenesis; Chiral medicinal products; CYP1A1 gene.

  • Metabolism of fibric acid derivatives. Spence, J.D. // Clinical Pharmacokinetics;1998, Vol. 34 Issue 5, p419 

    Presents an apology from the editorial staff of 'Clinical Pharmacokinetics' concerning the publishing of an article about the clinical pharmacokinetics of fibric acid derivatives. Metabolism by cytochrome P450 (CYP) 3A4; Information on the involvement of enzymes in the metabolism process;...

  • Drugs in nails: physiology, pharmacokinetics and forensic toxicology. Palmeri, A.; Pichini, S.; Pacifici, R.; Zuccaro, P.; Lopez, A. // Clinical Pharmacokinetics;2000, Vol. 38 Issue 2, p95 

    In recent years, drug analysis in keratinised matrices, such as hair and nails, has received considerable attention because of several advantages over drug testing methodologies employing body fluids, such as urine or serum. For example, keratinic matrices, such as finger- and toenails, can...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics